NYSE:ACH Accendra Health (ACH) Stock Price, News & Analysis $0.13 -0.02 (-11.64%) As of 11/13/2026 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC Filings About Accendra Health Stock (NYSE:ACH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Accendra Health alerts:Sign Up Key Stats Today's Range$0.12▼$0.1450-Day Range$0.13▼$1.2252-Week Range$0.12▼$4.69Volume1.97 million shsAverage Volume4.36 million shsMarket Capitalization$9.93 millionP/E RatioN/ADividend YieldN/APrice Target$1.50Consensus RatingReduce Company Overview Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions. Read More Accendra Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScoreACH MarketRank™: 1.44320420223 of 5 starsAccendra Health scored higher than 29% of companies evaluated by MarketBeat, and ranked 728th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingReduce Consensus RatingAccendra Health has received a consensus rating of Reduce. The company's average rating score is 1.80, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and 1 sell rating.Upside PotentialAccendra Health has a consensus price target of $1.50, representing about 1,062.8% upside from its current price of $0.13.Amount of Analyst CoverageAccendra Health has only been the subject of 2 research reports in the past 90 days.Read more about Accendra Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Accendra Health are expected to grow in the coming year, from ($0.03) to $0.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Accendra Health is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Accendra Health is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.26% of the float of Accendra Health has been sold short.Short Interest Ratio / Days to CoverAccendra Health has a short interest ratio ("days to cover") of 4.05.Change versus previous monthShort interest in Accendra Health has recently increased by 11.34%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAccendra Health does not currently pay a dividend.Dividend GrowthAccendra Health does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A Search Interest14 people have searched for ACH on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Accendra Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Accendra Health insiders have not sold or bought any company stock.Percentage Held by Insiders0.63% of the stock of Accendra Health is held by insiders.Percentage Held by InstitutionsAccendra Health has minimal institutional ownership at this time.Read more about Accendra Health's insider trading history. Receive ACH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Accendra Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACH Stock News HeadlinesAccendra (ACH) Q3 2026 Earnings Call TranscriptNovember 6, 2026 | finance.yahoo.comAccendra Health, Inc. (ACH) Q3 2026 Earnings Call TranscriptNovember 6, 2026 | seekingalpha.comI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.November 15 at 1:00 AM | Behind the Markets (Ad)Accendra Health Renews $150 Mln Receivables Sale ProgramNovember 2, 2026 | rttnews.comAccendra Health Announces Extension of $150 Million Receivables Sale Program To 2029November 2, 2026 | businesswire.comAccendra Health, Inc. Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders' Equity; Intends to Submit Business Plan and Return ...October 31, 2026 | finanznachrichten.deAccendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to ...October 30, 2026 | marketscreener.comMAccendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders' Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing StandardOctober 30, 2026 | businesswire.comSee More Headlines ACH Stock Analysis - Frequently Asked Questions How have ACH shares performed this year? Accendra Health's stock was trading at $2.64 on April 9, 2026. Since then, ACH stock has decreased by 95.1% and is now trading at $0.1290. How were Accendra Health's earnings last quarter? Accendra Health, Inc. (NYSE:ACH) posted its quarterly earnings data on Thursday, November, 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.18. The firm had revenue of $601.78 million for the quarter. Accendra Health had a negative net margin of 6.72% and a negative trailing twelve-month return on equity of 4.02%. Who are Accendra Health's major shareholders? Accendra Health's top institutional investors include Williams & Novak Wealth Management LLC (0.15%), Ground Swell Capital LLC (0.14%) and Empowered Funds LLC (0.14%). How do I buy shares of Accendra Health? Shares of ACH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/05/2026Today11/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ACH's financial health is in the Red zone, according to TradeSmith. ACH has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:ACH CIK75252 Webwww.accendrahealth.com Phone(804) 277-4304Fax804-723-7100Employees6,500Year Founded1882Price Target and Rating Average Price Target for Accendra Health$1.50 High Price Target$1.50 Low Price Target$1.50 Potential Upside/Downside+1,062.8%Consensus RatingReduce Rating Score (0-4)1.80 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($2.22) Trailing P/E RatioN/A Forward P/E Ratio1.43 P/E GrowthN/ANet Income-$1.10 billion Net Margins-6.72% Pretax Margin-5.83% Return on Equity-4.02% Return on Assets-0.83% Debt Debt-to-Equity RatioN/A Current Ratio0.41 Quick Ratio0.29 Sales & Book Value Annual Sales$2.73 billion Price / Sales0.00 Cash Flow$3.23 per share Price / Cash Flow0.04 Book Value($7.38) per share Price / Book-0.02Miscellaneous Outstanding Shares76,960,000Free Float76,480,000Market Cap$9.93 million OptionableOptionable Beta1.60 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NYSE:ACH) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accendra Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Accendra Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.